PCI 3.06.26
Wallonia

Current Edition

Current Features

Biomanufacturing

Mastering ADC Bioconjugation: From DAR Control to Efficient Free Payload Removal

Continue reading

Upcoming Events

Auto Draft
CPHI
Bioprocessing summit
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Congenital Hyperinsulinism Treatment Gaps and a Potential Solution

Although rare diseases, by definition, affect fewer individuals than other diseases do, they tend to be particularly devastating: they are often debilitating or lethal. It is estimated that as many as 7000 rare diseases exist globally. While the number of individuals with a specific rare disease may be small, the total number of people with any rare disease is quite large. Dr. Roberts at Rezolute, Inc. discusses new avenues of treatment for congenital HI.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2020/07/Congenital-Hyperinsulinism-Treatment-Gaps.pdf”]

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity